{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Retina Unplugged","title":"Common Practice Dilemmas in the Age of Second-Generation Therapy","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/93823b10\"></iframe>","width":"100%","height":180,"duration":1826,"description":"Please CLICK HERE (www.paradigmmc.com/1401) to review the CME information and complete the pretest for this activity.\n\nTreatment paradigms are shifting with the advent of second-generation therapies (eg, faricimab and aflibercept 8 mg) for retinal vascular disease. How will this affect your practice? Listen to renowned experts as they share their own experiences with second-generation therapies and discuss related innovations, clinical challenges, and practical solutions (eg, optical coherence tomography monitoring, the role of biomarkers, and patient engagement) in this lively podcast activity.\nWhen you are finished, please CLICK HERE (www.paradigmmc.com/1401) to complete the posttest and evaluation.\nTRANSCRIPT\nREFERENCES","thumbnail_url":"https://img.transistorcdn.com/4qqqohCPmbThXxg5qxImMjFsYUhNSK4MuHxsh163VlU/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iNWQy/OTZiNTZhODFjMmZi/ZjJhMWVhNzVjNWJk/NDY3OS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}